GSA Capital Partners’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-99,662
| Closed | -$95K | – | 1563 |
|
|
2024
Q3 | $95K | Buy |
+99,662
| New | +$95K | 0.01% | 1495 |
|
|
2024
Q2 | – | Sell |
-370,179
| Closed | -$585K | – | 1583 |
|
|
2024
Q1 | $585K | Sell |
370,179
-138,629
| -27% | -$219K | 0.05% | 790 |
|
|
2023
Q4 | $403K | Buy |
+508,808
| New | +$403K | 0.03% | 936 |
|
|
2023
Q3 | – | Sell |
-34,307
| Closed | -$32K | – | 1446 |
|
|
2023
Q2 | $32K | Sell |
34,307
-14,330
| -29% | -$13.4K | ﹤0.01% | 1432 |
|
|
2023
Q1 | $53K | Sell |
48,637
-92,447
| -66% | -$101K | 0.01% | 1398 |
|
|
2022
Q4 | $206K | Sell |
141,084
-239,959
| -63% | -$350K | 0.03% | 1168 |
|
|
2022
Q3 | $410K | Buy |
+381,043
| New | +$410K | 0.05% | 722 |
|
|
2022
Q2 | – | Sell |
-69,612
| Closed | -$143K | – | 1347 |
|
|
2022
Q1 | $143K | Sell |
69,612
-14,517
| -17% | -$29.8K | 0.02% | 1238 |
|
|
2021
Q4 | $315K | Sell |
84,129
-400,653
| -83% | -$1.5M | 0.04% | 894 |
|
|
2021
Q3 | $2.51M | Sell |
484,782
-28,606
| -6% | -$148K | 0.26% | 30 |
|
|
2021
Q2 | $2.19M | Buy |
513,388
+420,276
| +451% | +$1.79M | 0.25% | 47 |
|
|
2021
Q1 | $494K | Sell |
93,112
-229,632
| -71% | -$1.22M | 0.08% | 359 |
|
|
2020
Q4 | $1.74M | Buy |
322,744
+248,797
| +336% | +$1.34M | 0.28% | 36 |
|
|
2020
Q3 | $590K | Buy |
+73,947
| New | +$590K | 0.1% | 303 |
|
|
2020
Q2 | – | Sell |
-19,219
| Closed | -$52K | – | 582 |
|
|
2020
Q1 | $52K | Sell |
19,219
-83,675
| -81% | -$226K | 0.01% | 957 |
|
|
2019
Q4 | $123K | Buy |
102,894
+33,189
| +48% | +$39.7K | 0.01% | 1321 |
|
|
2019
Q3 | $105K | Buy |
69,705
+12,060
| +21% | +$18.2K | 0.01% | 1272 |
|
|
2019
Q2 | $232K | Sell |
57,645
-11,464
| -17% | -$46.1K | 0.03% | 1165 |
|
|
2019
Q1 | $297K | Buy |
+69,109
| New | +$297K | 0.03% | 1000 |
|
|
2018
Q2 | – | Sell |
-75,912
| Closed | -$852K | – | 1635 |
|
|
2018
Q1 | $852K | Buy |
+75,912
| New | +$852K | 0.05% | 765 |
|
|
2017
Q3 | – | Sell |
-53,866
| Closed | -$242K | – | 1566 |
|
|
2017
Q2 | $242K | Buy |
+53,866
| New | +$242K | 0.02% | 1418 |
|
|
2016
Q4 | – | Sell |
-11,803
| Closed | -$83K | – | 1719 |
|
|
2016
Q3 | $83K | Buy |
+11,803
| New | +$83K | ﹤0.01% | 1710 |
|